about
Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS)Hormone therapy for endometriosis and surgical menopauseOvarian cyst aspiration prior to in vitro fertilization treatment for subfertilityThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsEffects of GnRH agonist treatment on steroidogenesis and folliculogenesis in the ovary of cyclic mice.Folliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model.Morphological and enzymatic changes caused by a long-term treatment of female rats with a low dose of gonadoliberin agonist and antagonistA regulatory loop between miR-132 and miR-125b involved in gonadotrope cells desensitization to GnRH.Pharmacokinetics and Bioavailability of the GnRH Analogs in the Form of Solution and Zn2+-Suspension After Single Subcutaneous Injection in Female RatsThe extrapituitary effects of GnRH antagonists and their potential clinical implications: a narrated review.Current and future applications of GnRH, kisspeptin and neurokinin B analogues.Doppler-ultrasound as a predictor of uterine fibroid response to GnRH therapy.Transplantation of CD51+ Stem Leydig Cells: A New Strategy for the Treatment of Testosterone Deficiency.Development of a subcutaneous endometriosis rat model.An analytical strategy to characterize the pharmacokinetics and pharmacodynamics of triptorelin in rats based on simultaneous LC-MS/MS analysis of triptorelin and endogenous testosterone in rat plasma.In VitroCharacterization of Six Month Dosage Forms for a GnRH Antagonist
P2860
Q24193315-1C587369-BE1F-4257-B3B6-D67F992DCEEEQ24240923-A1D1CF8D-3896-40E3-83D9-F8675D56D075Q24244397-61DEDA80-665B-4FDE-8B80-8E13CDCEAE47Q30486707-79A7B9F7-3EAA-4EC3-B8D0-F6DEC78CBCBCQ34388026-D48B3B30-C325-478D-84A5-E4AE0F158BB7Q35760872-ACCDA1BA-05EC-4C11-81D2-7F44889C5F51Q36577239-C71CB489-E6D3-4130-AA7E-805598C69CC9Q37188926-F142CA9E-7F42-471B-BB7D-D51E2C4BE25EQ37685499-21FD80A8-CF26-448C-8C87-530006DC71C0Q38046587-A242E8A3-BF3C-4370-93CD-E50BE0D86873Q38118569-9FF7F8BF-9AF8-4405-8338-537B14B11CB4Q44497356-9B402298-EF85-45BC-BD60-0A3D09B7AFDEQ48355731-BE227C47-2746-495F-B5C0-C11147A90B5DQ51061722-2D3921B4-1FF5-40BB-90DD-85B233C432F3Q51753969-AB3CE4D3-5A7A-4D4C-872C-40F55DE508EBQ59051344-0B46749B-1A0D-4AD3-BE8A-CF92D28B696B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical use of GnRH analogues.
@ast
Clinical use of GnRH analogues.
@en
Clinical use of GnRH analogues.
@nl
type
label
Clinical use of GnRH analogues.
@ast
Clinical use of GnRH analogues.
@en
Clinical use of GnRH analogues.
@nl
prefLabel
Clinical use of GnRH analogues.
@ast
Clinical use of GnRH analogues.
@en
Clinical use of GnRH analogues.
@nl
P2093
P2860
P1476
Clinical use of GnRH analogues.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2265.2002.01291.X
P577
2002-06-01T00:00:00Z